Moscow–India: industrial partnership between the two countries discussed in New Delhi

The Iphex and Pharma MachTech LabNext Expo exhibitions were held in New Delhi (India) from September 7 to 9, 2026, at the Bharat Mandapam exhibition centre. It was a large‑scale event that brought together the key trends in the pharmaceutical industry: from drug production to laboratory equipment and packaging.

Representatives of the pharmaceutical industry held talks with Pharmexcil – the Council for the Promotion of Exports of Pharmaceutical Products of India. During the meeting, the Indian side was presented with the investment and infrastructure potential of the Technopolis Moscow special economic zone and discussed the possibilities of locating production facilities in the capital of Russia. The negotiations were attended by the council’s leadership: Chairman Namit Joshi, General Director Raja Banu, and Directors Kamal Bhardwaj and John Rollin.

Moscow is the national center for the production of pharmaceutical and medical products. The Technopolis Moscow special economic zone is the flagship for the development of advanced solutions in these industries. At a meeting with colleagues from the Council for the Promotion of Pharmaceutical Exports of India, they presented the infrastructural and investment potential of the SEZ, in particular the Alabushevo site, where the most powerful industry cluster in the country is being formed. Today, it unites 14 leading enterprises – they create unique high-tech solutions that are in demand throughout the country. The Indian side has shown interest in entering the Russian market by localizing its manufacturers in the Russian capital. In addition, representatives of the council expressed hope for the creation of joint educational initiatives, including training and practical training for students to develop the human potential of the pharmaceutical industry.

During the meeting, the Indian colleagues were told about the various SEZ sites where greenfield and brownfield projects are available for implementation. In the first case, this refers to the construction of new high‑tech production facilities, and in the second — to the placement of modern companies in the ready‑made infrastructure of the capital’s SEZ. Companies with SEZ resident status are entitled to a wide range of preferences: they are exempt from paying property, transport and land taxes for a period of 10 years, and the corporate income tax rate will be reduced 12.5‑fold — to two percent.

Moscow delegates also drew attention to the single window regime for foreign investors. The meeting participants agreed to continue negotiations on mutually beneficial cooperation and the implementation of joint projects in Moscow.

Pharmexcil was established by the Ministry of Commerce and Industry of India. The council is engaged in promoting a wide range of pharmaceutical and medical products: from substances and finished dosage forms to diagnostic equipment. It also helps local exporters find foreign partners and facilitates the localization of production by local companies abroad.

From September 7 to 9, the industry exhibition Pharma MachTech LabNext Expo 2026 was also held in New Delhi. The collective stand “Made in Moscow” featured solutions from leading enterprises in Moscow’s medical industry: sterilization equipment from a resident of the special economic zone, reagents, as well as solutions for providing emergency medical care and robots for the pharmaceutical industry.